AA
ARKG icon

AlphaMark Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

AlphaMark Advisors’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$88K Hold
3,735
– – 0.04% 189
2024
Q3 		$96K Hold
3,735
– – 0.03% 283
2024
Q2 		$88K Sell
3,735
-1,250
-25% -$31.5K 0.03% 294
2024
Q1 		$143K Sell
4,985
-125
-2% -$3.76K 0.05% 242
2023
Q4 		$168K Buy
5,110
+215
+4% +$5.85K 0.06% 234
2023
Q3 		$136K Buy
4,895
+100
+2% +$3.27K 0.06% 233
2023
Q2 		$163K Buy
4,795
+225
+5% +$7.07K 0.08% 121
2023
Q1 		$137K Buy
4,570
+505
+12% +$15.6K 0.06% 136
2022
Q4 		$115K Sell
4,065
-530
-12% -$16.8K 0.06% 139
2022
Q3 		$151K Sell
4,595
-55
-1% -$2.02K 0.07% 115
2022
Q2 		$146K Sell
4,650
-175
-4% -$6.12K 0.07% 120
2022
Q1 		$222K Buy
4,825
+415
+9% +$19.8K 0.08% 116
2021
Q4 		$270K Sell
4,410
-425
-9% -$29.4K 0.09% 115
2021
Q3 		$361K Buy
4,835
+140
+3% +$11.7K 0.13% 96
2021
Q2 		$434K Sell
4,695
-205
-4% -$17.4K 0.16% 85
2021
Q1 		$435K Buy
+4,900
New +$486K 0.17% 82

Other funds holding ARKG

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

AlphaMark Advisors's ARKG Position: Q4 2024 in Review

AlphaMark Advisors held its ARK Genomic Revolution ETF (ARKG) position steady in Q4 2024 at 3,735 shares worth $88K. The position accounts for 0.04% of the portfolio, ranked #189.

AlphaMark Advisors first reported a position in ARKG in Q1 2021 and has held it in 16 quarters since. The position peaked at $435K in Q1 2021. 238 funds tracked by Wall St. Rank hold ARKG as of Q4 2024.

  • AlphaMark Advisors held 3,735 shares of ARK Genomic Revolution ETF worth $88K as of Q4 2024.
  • AlphaMark Advisors left its ARK Genomic Revolution ETF share count unchanged in Q4 2024.
  • ARK Genomic Revolution ETF made up 0.04% of AlphaMark Advisors's portfolio in Q4 2024, its #189 holding.
  • AlphaMark Advisors first reported a position in ARK Genomic Revolution ETF in Q1 2021 and has held it in 16 quarters since.
  • AlphaMark Advisors's ARK Genomic Revolution ETF position peaked at $435K in Q1 2021.
  • 238 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2024.

Based on AlphaMark Advisors's 13F filing for Q4 2024, filed 21 Jan 2025.